Low serum fibroblast growth factor 2 levels not accompanied by increased serum pentraxin 3 levels in patients with systemic sclerosis

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus

Michelle Petri, Ana‐Maria Orbai, Graciela S. Alarcón et al. · Arthritis & Rheumatism · 2012 · 5.3K citations · Full text

Life Sciences, Immunology, Clinical Classification Systems +11

Scleroderma (systemic sclerosis): classification, subsets and pathogenesis

E. Carwile LeRoy, Casilda G. Black, Raúl Fleischmajer et al. · 2001 · 4K citations

Medicine, Pathobiology, Pathology +10

2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative

F.H.J. van den Hoogen, Dinesh Khanna, Jaap Fransen et al. · Arthritis & Rheumatism · 2013 · 3.4K citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15

Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers

Oliver Distler, Angela Del Rosso, Roberto Giacomelli et al. · Arthritis Research & Therapy · 2002 · 279 citations · Full text

Medicine, Clinical Sciences, Immunology +9

Expression and production of the long pentraxin PTX3 in rheumatoid arthritis (RA)

Michele Maria Luchetti, Giulia Piccinini, Alberto Mantovani et al. · Clinical & Experimental Immunology · 2000 · 186 citations · Full text

Life Sciences, Immunology, Pathobiology +11